CPTx
CA - South SFBiotechnology
Focus: CPTx is a biotechnology company specializing in gene-encoding single-stranded DNA therapeutics, headquartered in South San Francisco. The company operates in the early-stage biotech segment with a focused platform approach.
Profile data last refreshed 5h ago · AI intelligence enriched 2w ago
Open Jobs
1
Should You Work at CPTx?
AI assessmentCPTx is a platform-stage biotech bet suitable for scientists and early-career professionals willing to accept execution risk in exchange for foundational impact in gene-encoding DNA technology.
Why Work Here
- Recently appointed Edward Rebar as Chief Scientific Officer (May 2026), signaling leadership depth in gene therapy and potential acceleration of scientific direction.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for CPTx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.